Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00869804 · ClinicalTrials.gov registry record · NA
Heading Off Peripheral Neuropathy With Exercise
A NA study, sponsored by University of Nebraska.
- Terminated
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT00869804 is a NA study that was terminated before completion, run by University of Nebraska. The registered enrollment target is 19 participants.
The verdict
NCT00869804, a NA study, was terminated before completion, sponsored by University of Nebraska.
- TERMINATED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
Chemotherapy for the treatment of breast cancer can affect nerves and muscles leading to loss of sensation in the hands and feet for feeling hot and cold, difficulty walking, and muscle weakness. This study will explore if exercises such as walking and strength training may prove helpful in preventing or lessening chemotherapy-induced peripheral neuropathy from chemotherapy, making the therapy easier to tolerate and increasing overall quality of life.
Interventions
- BEHAVIORAL Attention control
- BEHAVIORAL Aerobic/ Resistance Exercise Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2009-03-25 |
| Est. Completion | 2011-12-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00869804
The ClinicalTrials.gov registry entry for NCT00869804 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Attention control is the first listed.
NCT00869804 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00869804 about?
NCT00869804 is a clinical study titled "Heading Off Peripheral Neuropathy With Exercise". Chemotherapy for the treatment of breast cancer can affect nerves and muscles leading to loss of sensation in the hands and feet for feeling hot and cold, difficulty walking, and muscle weakness. This study will explore if exercises such as walking and strength training may prove helpful in preventi...
What is the current status of trial NCT00869804?
This trial is currently terminated. It is a NA study. The enrollment target is 19 participants. The study started on 2009-03-25. Estimated completion is 2011-12-13.
What interventions are being tested in trial NCT00869804?
The interventions under investigation include: Attention control (BEHAVIORAL), Aerobic/ Resistance Exercise Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00869804?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.